Drinking Water Lithium Tracks With Higher Childhood Wolff-Parkinson-White Prevalence
A county-level ecological analysis from California links higher lithium concentrations in drinking water with a greater prevalence of childhood-diagnosed Wolff-Parkinson-White syndrome. The finding is provocative because it points toward an environmental exposure that may influence formation of atrioventricular accessory pathways long before symptoms bring a child to medical attention.
The study examined whether in utero exposure to lithium from environmental sources could be tied to the later prevalence of accessory pathways, the anatomic substrate for supraventricular tachycardia and WPW. Investigators focused on children younger than 18 years, reasoning that most would have remained in the same county during fetal development, and therefore would better reflect local water exposure than an adult cohort with greater residential mobility. Diagnostic codes identified WPW cases, and multivariable logistic regression was used to compare lithium levels in drinking water with diagnosis prevalence. Positive and negative controls, including falsification endpoints, were also incorporated to test whether the association behaved as a real signal rather than a spurious artifact.
Among 2,329,090 patients, the mean age was 8.2 ± 5.9 years and 47.8% were female. Only 686 children, or 0.03%, carried a WPW diagnosis, which reflects how uncommon the disorder remains at the population level even while it can generate dramatic clinical presentations. In counties where lithium levels were at or above the 75th percentile, the odds of WPW were 71% higher than in lower-exposure areas (OR 1.71, 95% CI 1.44 to 2.03). Counties above the lithium health-based screening limit still showed increased odds, with a smaller but statistically supported effect size (OR 1.29, 95% CI 1.05 to 1.58).
The signal did not stop at one state border. Similar results emerged in a statewide New York cohort, which strengthens the case that the pattern is not unique to California’s water chemistry or referral network. In validation analyses, higher lithium exposure areas also showed greater prevalence of supraventricular tachycardia, syncope, palpitations, and catheter ablation procedures. Those linked outcomes matter clinically because they represent the pathway from latent conduction abnormality to symptomatic arrhythmia and, ultimately, procedural treatment.
A single sentence captures the clinical weight of the result: a routine environmental exposure was associated with a congenital arrhythmia substrate that often goes unnoticed until it causes symptoms.
Biologic plausibility rests on lithium’s long-standing relationship with cardiac development. Lithium exposure has already been tied to Ebstein’s anomaly when used medicinally during pregnancy, and Ebstein’s anomaly is itself associated with accessory pathways. The new association raises the possibility that lower-level environmental lithium exposure could influence embryologic development of the atrioventricular conduction system, even if the mechanism remains undefined. Accessory pathway formation is a developmental event, not an acquired adult process, so any exposure that alters early cardiac patterning could leave a durable electrophysiologic footprint.
Ecological studies cannot prove causation, and this one is no exception. County-level exposure estimates cannot capture individual-level drinking water intake, bottled water use, dietary sources, renal handling, or other exposures that may modify lithium burden. Diagnosis codes also reflect health care access, clinician recognition, and coding practices, all of which can shape apparent prevalence. Still, the use of large population datasets, multivariable adjustment, and validation across two states gives the analysis more credibility than a simple geographic correlation.
The practical implication is not a new screening mandate. It is a reason to take environmental lithium seriously as a candidate contributor to pediatric arrhythmia risk, especially in regions where background water concentrations are elevated. If future work confirms the association at the individual level, obstetric exposure history and regional water chemistry could become relevant pieces of a WPW risk assessment. For now, the strongest message is narrower and more concrete: accessory pathway prevalence appears to rise in step with higher environmental lithium exposure.
The study also invites a broader question about how many congenital conditions sit downstream of exposures that are usually considered too small to matter. In electrophysiology, small shifts in early conduction development can produce outsized clinical effects later in life, because a single accessory pathway can generate symptomatic tachycardia, syncope, or the need for catheter ablation. The present findings fit that biology. They do not prove that lithium in water causes WPW, but they place environmental lithium squarely on the map as a modifiable variable worthy of deeper mechanistic and epidemiologic follow-up.